No Data
No Data
Why Citius Pharmaceuticals (CTXR) Stock Is Down 15%
Citius Pharmaceuticals Falls as It Looks to Raise $3M in Direct Offering
Express News | Citius Pharmaceuticals Announces $3 Million Registered Direct Offering Priced at-the-Market Under Nasdaq Rules
Citius Pharmaceuticals Announces $3 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Sector Update: Health Care
Citius Pharmaceuticals Is Maintained at Buy by D. Boral Capital